Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Oct 24, 2023 4:55pm
RE:New low…… Howard continues his winning streak
There are only two ways to make money here for us, that's buy low and sell high, or short sell high and buy back low. Howard is building his war chest with his incompetence, and at this point the
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Post by
Pareto8020
on Oct 24, 2023 3:19pm
New low…… Howard continues his winning streak
Wow 7.5 cents.....52 week low and probably a 5+ year low. Market has had enough of CEO's hollow promises and no results. At what point does Howard get the hell out of the way or a
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Oct 24, 2023 1:41pm
What will it take to get this to double digits?
I see some aaswhole from National Bank sold 1,000 share at 8 cents today. I hope that same idiot reads this post and realizes that they shouldn't be an investor with a lame move like that
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Oct 23, 2023 11:32am
RE:RE:RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
And yet all we get from Howie is crickets. One has to wonder if he can't find a single positive thing to say, maybe there is nothing but bad news coming?
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Oct 23, 2023 10:02am
RE:RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
i dont think anyone here is looking to either compromise the contract agreement or seek details about the agreement that are not available to share. Having a non compliance clause in an agreement such
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Oct 23, 2023 8:54am
RE:RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
Maybe if Howie would tell the owners of SBM, THE SHAREHOLDERS, what the heck was going on, there wouldn't be any issues? This garbage about "confidential" contract detail has to stop
...more
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Oct 23, 2023 7:48am
RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
Please do not post contract information. There can be heavy penalties for Michelle and sirona if allergan gets this out. I think it has its reasons why Michelle was terminated....
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Oct 22, 2023 10:10pm
RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
Selective disclosure is even worse. But nothing new for Vulture stocks. But I don't see why Abbvie wouldn't at least make some attempt, no matter how pathetic, to try to get a product out
...more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Oct 22, 2023 12:01pm
RE:RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
Mgmt silence on the Abbvie deal is stupidly excessive. Michelle told me that the deal does contain performance clauses where Abbvie must commercialize within a certain period or lose exclusivity
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Oct 22, 2023 7:22am
RE:RE:RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
The science is worthless unless they can produce a product, and so far Howie has failed spectacularly at that objective. If Abbvie ever actually does something, then and only then can we celebrate
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Oct 21, 2023 10:45pm
RE:RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
Not exactly but we need to watch this space moving forward. How many times have we seen 1. Dead silence which results in a steady slide as we all start to wonder, then 2. Crappy financials, then 3
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Oct 21, 2023 5:09pm
RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
So you are saying that they illegally manipulate the release of news in order to push the share price down when they want to accumulate? Interesting accusation.
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Oct 21, 2023 2:44pm
RE:RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
I don't see this actual transaction disclosure as positive or negative. This information on the option was disclosed prior. What pisses me off is when they fart around with the news flow
...more
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Oct 21, 2023 12:09pm
Tylerreddick, I second your motion of: UP YOURS HOWIE
What a rip off at 6.5cents a share. Now he'll sell those and make $$$$, a lot more than the 12% interest. We have been played for years. How can this guy sleep at night? How can
...more
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >